IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients

被引:1
|
作者
Mauricio Venegas [1 ]
Rodrigo A Villanueva [2 ]
Katherine González [1 ]
Javier Brahm [1 ]
机构
[1] Centro de Estudios Avanzados de las Hepatitis Virales,Sección de Gastroenterología,Departamento de Medicina,Hospital Clínico Universidad de Chile
[2] Centro de Estudios Avanzados de las Hepatitis Virales,Laboratorio de Virus Hepatitis,Programa de Virología,Instituto de Ciencias Biomédicas,Facultad de Medicina,Universidad de Chile
关键词
IL28B; Hepatitis C virus; Chile; Pegylated interferon; Ribavirin;
D O I
暂无
中图分类号
R512.63 [];
学科分类号
100401 ;
摘要
AIM:To analyze the association of three IL28B single nucleotide polymorphisms with response to therapy in Chilean patients infected with hepatitis C virus CV.METHODS:We studied two groups of patients with chronic CV infection genotype 1,under standard combined treatment with pegylated interferon plus ribavirin.One group consisted of 50 patients with sustained virological response,whereas the second group consisted of 49 null responders.In order to analyze the IL28B single nucleotide polymorphisms rs12979860,rs12980275 and rs8099917,samples were used for polymerase chain reaction amplification,and the genotyping was performed by restriction fragment lengthpolymorphism.RESULTS:The IL28B rs12979860 CC,rs12980275 AA and rs8099917 TT genotypes were much more frequently found in patients with sustained virological response compared to null responders 38%,44% and 50% vs 2%,8.2% and 8.2%,respectively.These differences were highly significant in all three cases(P < 0.0001.CONCLUSION:The three IL28B polymorphisms studied are strongly associated with sustained virological response to therapy in Chilean patients with chronic CV genotype 1.
引用
收藏
页码:3636 / 3639
页数:4
相关论文
共 50 条
  • [21] IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population
    Cavalcante, Lourianne N.
    Abe-Sandes, Kiyoko
    Angelo, Ana Luisa D.
    Machado, Taisa M. B.
    Lemaire, Denise C.
    Mendes, Carlos M. C.
    Pinho, Joao R.
    Malta, Fernanda
    Lyra, Luiz G. C.
    Lyra, Andre C.
    LIVER INTERNATIONAL, 2012, 32 (03) : 476 - 486
  • [22] Association of IL28B polymorphisms with virological response to peginterferon and ribavirin therapy in children and adolescents with chronic hepatitis C
    Tajiri, Hitoshi
    Tanaka, Yasuhito
    Takano, Tomoko
    Suzuki, Mitsuyoshi
    Abukawa, Daiki
    Miyoshi, Yoko
    Shimizu, Toshiaki
    Brooks, Stephen
    HEPATOLOGY RESEARCH, 2014, 44 (10) : E38 - E44
  • [23] IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection
    Abdo, Ayman A.
    Al-Ahdal, Mohammed N.
    Khalid, Saira S.
    Helmy, Ahmed
    Sanai, Faisal M.
    Alswat, Khalid
    Al-hamoudi, Waleed
    Ali, Safiyya M.
    Al-Ashgar, Hamad I.
    Al-Mdani, Abdallah
    Albenmousa, Ali
    Al Faleh, Faleh Z.
    Al-Anazi, Mashael
    Khalaf, Nisreen
    Al-Qahtani, Ahmed
    HEPATOLOGY INTERNATIONAL, 2013, 7 (02) : 533 - 538
  • [24] IL28B GENOTYPE IS NOT ASSOCIATED WITH INSULIN RESISTANCE IN CHRONIC HEPATITIS C PATIENTS
    Degasperi, E.
    Valenti, L.
    Aghemo, A.
    De Francesco, R.
    Soffredini, R.
    D'Ambrosio, R.
    Rumi, M.
    Donnici, L.
    Cheroni, C.
    Zanoni, V.
    Orsi, E.
    Colombo, M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S183 - S183
  • [25] IL28B Polymorphisms and Influence on Sustained Virological Response to Interferon Therapy in Chronic DELTA Hepatitis
    Karaca, Cetin
    Yilmaz, Emre
    Soyer, Ozlem Mutluay
    Onel, Derya
    Onel, Mustafa
    Baran, Bulent
    Ormeci, Asli
    Gokturk, Suut
    Evirgen, Sami
    Akyuz, Filiz
    Demir, Kadir
    Besisik, Fatih
    Kaymakoglu, Sabahattin
    GASTROENTEROLOGY, 2013, 144 (05) : S972 - S972
  • [26] POLYMORPHISMS NEAR THE IL28B GENE ARE NOT ASSOCIATED WITH RESPONSE TO PEGINTERFERON IN HBeAg-NEGATIVE CHRONIC HEPATITIS B PATIENTS
    Brouwer, W. P.
    Arends, P.
    Rijckborst, V.
    ter Borg, M. J.
    Cakaloglu, Y.
    Ferenci, P.
    Tabak, F.
    Akdogan, M.
    Simon, K.
    Raptopoulou-Gigi, M.
    Ormeci, N.
    Akarca, U. S.
    Flisiak, R.
    Hansen, B.
    Boonstra, A.
    Janssen, H. L. A.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S299 - S299
  • [27] Single nucleotide polymorphisms near IL28B gene and response to treatment of chronic hepatitis C in hemodialysis patients
    Dzekova-Vidimliski, Pavlina
    Nikolov, Igor G.
    Matevska-Geshkovska, Nadica
    Mena, Sami
    Rostaing, Lionel
    Dimovski, Aleksandar
    Sikole, Aleksandar
    RENAL FAILURE, 2015, 37 (07) : 1180 - 1184
  • [28] IL28B POLYMORPHISMS MAY IMPROVE RESPONSE TO HEPATITIS C THERAPY AFTER LIVER TRANSPLANTATION
    Coto-Llerena, Mairene
    Perez-del-Pulgar, Sofia
    Crespo, Gonzalo
    Gonzalez, Patricia
    Mensa, Laura
    Dragun, Jakub
    Koutsoudakis, George
    Martorell, Jaume
    Navasa, Miquel
    Forns, Xavier
    HEPATOLOGY, 2010, 52 (04) : 867A - 867A
  • [29] Association of IL28B polymorphisms with hepatitis C infection
    Doehring, A.
    Hofmann, W. P.
    Schlecker, C.
    Zeuzem, S.
    Geisslinger, G.
    Sarrazin, C.
    Lotsch, J.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2010, 381 : 91 - 91
  • [30] Impaired IL28B gene induction and poor IL28B promoter activity influenced by the IL28B minor allele are closely associated with a null response to interferon in chronic hepatitis C patients
    Asahina, Yasuhiro
    Murakawa, Miyako
    Sakamoto, Naoya
    Kakinuma, Sei
    Nakagawa, Mina
    Azuma, Seishin
    Nishimura-Sakurai, Yuki
    Nitta, Sayuri
    Kusano-Kitazume, Akiko
    Watanabe, Mamoru
    HEPATOLOGY, 2012, 56 : 697A - 698A